DEXCOM, INC. Available-for-sale Securities
DEXCOM, INC. (DXCM) had Available-for-sale Securities of $301.30 million as of 2018-09-30, per its 10-Q filed 2018-11-06.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecurities · last filed 2018-11-06
- 2018-09-30: Available-for-sale Securities $301.30M.
- 2018-06-30: Available-for-sale Securities $305.90M.
- 2018-03-31: Available-for-sale Securities $113.50M.
- 2017-12-31: Available-for-sale Securities $107.10M.
| Period end | Available-for-sale Securities |
|---|---|
| 2018-09-30 | $301.30M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $305.90M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $113.50M 10-Q · filed 2018-05-02 |
| 2017-12-31 | $107.10M 10-Q · filed 2018-11-06 |
| 2017-09-30 | $123.70M 10-Q · filed 2017-11-01 |
| 2017-06-30 | $100.70M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $27.60M 10-Q · filed 2017-05-02 |
| 2016-12-31 | $29.20M 10-K · filed 2018-02-27 |
| 2016-09-30 | $29.60M 10-Q · filed 2016-11-01 |
| 2016-06-30 | $28.10M 10-Q · filed 2016-08-02 |
| 2016-03-31 | $28.60M 10-Q · filed 2016-04-27 |
| 2015-12-31 | $29.10M 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |